Form 4 for MBIO MUSTANG BIO, INC.
Accepted 2024-06-04 00:00:00 ET · period of report 2024-05-31 · accession 0001104659-24-068411 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-04 | 2024-05-31 | MBIO | Litchman Manuel MD | Pres, CEO, Dir | F - Tax | $0.35 | -1,396 | 83.0K | -2% | -$488.60 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-31 | F | D | 1,396 | $0.35 | 83,024 | D | — | — | (F1) 1,396 shares of common stock were relinquished to cover tax liability associated with the delivery of shares of common stock upon the vesting of restricted stock units. (F2) Includes 5,000 shares of common stock acquired under the Mustang Bio, Inc. Employee Stock Purchase Plan on March 1, 2024. |